Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.39
+0.57 (7.29%)
At close: Mar 13, 2026, 4:00 PM EDT
8.40
+0.01 (0.12%)
After-hours: Mar 13, 2026, 7:59 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States Revenue
113.01M14.21M
United States Revenue Growth
695.06%45751.61%
Europe Revenue
278.00K531.00K
Europe Revenue Growth
-47.65%-10.15%
Revenue (Other)
--
Revenue (Total)
113.29M14.75M
Revenue (Total) Growth
668.32%2270.58%

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Product Revenue
112.98M14.15M
Product Revenue Growth
698.46%-
Other Revenue
306.00K595.00K
Other Revenue Growth
-48.57%-4.34%
Revenue (Total)
113.29M14.75M
Revenue (Total) Growth
668.32%2270.58%
Updated Feb 23, 2026. Data Source: Fiscal.ai.